BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17211695)

  • 1. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease.
    Dore MP; Pedroni A; Pes GM; Maragkoudakis E; Tadeu V; Pirina P; Realdi G; Delitala G; Malaty HM
    Dig Dis Sci; 2007 Feb; 52(2):463-8. PubMed ID: 17211695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical presentations of gastroesophageal reflux disease.
    Heidelbaugh JJ; Gill AS; Van Harrison R; Nostrant TT
    Am Fam Physician; 2008 Aug; 78(4):483-8. PubMed ID: 18756656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficiency of two different proton pump inhibitor formula in treatment of patients with atypical gastroesophageal reflux disease: a prospective randomized study.
    Lin XH; Luo JC; Ting PH; Chang TE; Huang YH; Hou MC; Lee FY
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2096-2102. PubMed ID: 32401385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globus sensation caused by gastroesophageal reflux disease.
    Tokashiki R; Yamaguchi H; Nakamura K; Suzuki M
    Auris Nasus Larynx; 2002 Oct; 29(4):347-51. PubMed ID: 12393039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-esophageal disorders in gastroesophageal reflux disease.
    Jaspersen D
    Dig Dis; 2004; 22(2):115-9. PubMed ID: 15383751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraesophageal symptoms: what role for the proton pump inhibitors?
    Nord HJ
    Am J Med; 2004 Sep; 117 Suppl 5A():56S-62S. PubMed ID: 15478854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic pharyngitis and laryngitis caused by gastroesophageal reflux].
    Tanabe T; Oridate N
    Nihon Rinsho; 2016 Aug; 74(8):1367-1371. PubMed ID: 30562444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics of gastroesophageal reflux disease in patients with laryngeal symptoms who are referred to gastroenterology.
    Oh JH; Choi MG; Park JM; Lim CH; Cho YK; Lee IS; Kim SW; Chung IS
    Dis Esophagus; 2013 Jul; 26(5):465-9. PubMed ID: 22816650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraesophageal manifestations in gastroesophageal reflux disease.
    Jaspersen D
    Minerva Gastroenterol Dietol; 2006 Sep; 52(3):269-74. PubMed ID: 16971871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
    Matsuhashi N; Kudo M; Yoshida N; Murakami K; Kato M; Sanuki T; Oshio A; Joh T; Higuchi K; Haruma K; Nakada K
    J Gastroenterol; 2015 Dec; 50(12):1173-83. PubMed ID: 25851931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
    Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
    Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraesophageal and atypical manifestations of GERD.
    Wong WM; Fass R
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S33-43. PubMed ID: 15324380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
    Kusano M; Hosaka H; Kawamura O; Kawada A; Kuribayashi S; Shimoyama Y; Yasuoka H; Mizuide M; Tomizawa T; Sagawa T; Sato K; Yamada M
    J Gastroenterol; 2015 Mar; 50(3):298-304. PubMed ID: 24919745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal reflux disease: clinical manifestations.
    Williams JL
    Gastroenterol Nurs; 2003; 26(5):195-200. PubMed ID: 14603078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing atypical manifestations of GERD. Asthma, chest pain, and otolaryngologic disorders may be due to reflux.
    Mujica VR; Rao SS
    Postgrad Med; 1999 Jan; 105(1):53-5, 60, 63-6. PubMed ID: 9924493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results.
    Galmiche JP
    Drugs; 2006; 66 Suppl 1():7-13; discussion 29-33. PubMed ID: 16869343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extraesophageal manifestations of gastroesophageal reflux disease].
    Kim GH
    Korean J Gastroenterol; 2008 Aug; 52(2):69-79. PubMed ID: 19077497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.